Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea

British Journal of Pharmacology

Volumn 141, Issue 7, 2004, Pages 1159-1166

  Moffatt, James D ^a   Cocks, Thomas M ^a,b   Page, Clive P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

5 HT; Acetylcholine; Airway; Epithelium

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; 5 CARBAMOYLTRYPTAMINE; ACETYLCHOLINE; AGATOXIN IVA; ALPHA METHYLSEROTONIN; ATROPINE; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CHOLINE ACETYLTRANSFERASE; KETANSERIN; METHACHOLINE; OMEGA CONOTOXIN GVIA; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC FIELD; ELECTROSTIMULATION; EPITHELIUM; EPITHELIUM CELL; FEMALE; GANGLION; IMMUNOREACTIVITY; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; TRACHEA; TRACHEA CONTRACTION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACETYLCHOLINE; ANIMALS; ATROPINE; BORON COMPOUNDS; BOTULINUM TOXIN TYPE A; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CARTILAGE; ELECTRIC STIMULATION; EPITHELIAL CELLS; EPITHELIUM; FEMALE; GANGLIA, PARASYMPATHETIC; KETANSERIN; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OMEGA-CONOTOXIN GVIA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEROTONIN; SURFACE-ACTIVE AGENTS; TETRODOTOXIN; TRACHEA;

EID: 2342622638     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705720     Document Type: Article

References (19)

1. ASCHER-LANDSBERG, J., SAUNDERS, T., ELOVITZ, M. & PHILLIPPE, M. (1999). The effects of 2-aminoethoxydiphenyl borate, a novel inositol 1,4,5-triphosphate receptor modulator on myometrial contractions. Biochem. Biophys. Res. Commun., 264, 979-982.
2. BARNES, P.J., CHUNG, K.F. & PAGE, C.P. (1998). Inflammatory mediators of asthma: an update. Pharmacol. Rev., 50, 515-596.
3. BLACK, J.W., LEFF, P. & SHANKLEY, N.P. (1985). Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach. Br. J. Pharmacol., 86, 589-599.
4. 2+ release. FASEB J., 16, 1145-1150.
5. BRAIN, K.L., TROUT, S.J., JACKSON, V.M., DASS, N. & CUNNANE, T.C. (2001). Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores. Neuroscience, 106, 395-403.
6. CAZZOLA, M. & MATERA, M.G. (2000). 5-HT modifiers as a potential treatment of asthma. Trends Pharmacol. Sci., 21, 13-16.
7. CUSHLEY, M.J., WEE, L.H. & HOLGATE, S.T. (1986). The effect of inhaled 5-hydroxytryptamine (5-HT, serotonin) on airway calibre in man. Br. J. Clin. Pharmacol., 22, 487-490.
8. COCKS, T.M., FONG, B., CHOW, J.M., ANDERSON, G.P., FRAUMAN, A.G., GOLDIE, R.G., HENRY, P.J., CARR, M.J., HAMILTON, J.R. & MOFFATT, J.D. (1999). A protective role for protease-activated receptors in the airways. Nature, 398, 156-160.
9. EUM, S.-Y., NOREL, X., LEFORT, J., LABAT, C., VARGAFTIG, B.B. & BRINK, C. (1999). Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholine. Br. J. Pharmacol., 126, 312-316.
10. HARKS, E.G.A., CAMINA, J.P., PETERS, P.H.J., YPEY, D.L., SCHEENEN, W.J.J.M., VAN ZOELEN, E.J.J. & THEUVENET, A.P.R. (2003). Besides affecting intracellular calcium signalling, 2-APB reversibly blocks gap junctional coupling in confluent monolayers, thereby allowing the measurement of single-cell membrane currents in undissociated cells. FASEB J., 17, 941-943.
11. HONG, S.J. & CHANG, C.C. (1995). Calcium channel subtypes for the sympathetic and parasympathetic nerves of guinea-pig atria. Br. J. Pharmacol., 116, 1577-1582.
12. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
13. HUMEAU, Y., DOUSSAU, F., GRANT, N.J. & POULAIN, B. (2000). How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie, 82, 427-446.
14. MCKUNE, C.M. & WATTS, S.W. (2001). Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. J. Pharmacol. Exp. Ther., 297, 88-95.
15. MORRIS, J.L., JOBLING, P. & GIBBINS, I.L. (2001). Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am. J. Physiol. Heart Circ. Physiol., 281, H2124-H2132.
16. TAKAHASHI, T., WARD, J.K., TADJKARIMI, S., YACOUB, M.D., BARNES, P.J. & BELVISI, M.G. (1995). 5-hydroxytryptamine facilitates cholinergic bronchoconstriction in human and guinea-pig airways. Am. J. Respir. Crit. Care Med., 152, 377-380.
17. UPHOUSE, L. (1997). Multiple serotonin receptors: too many, not enough, or just the right number? Neurosci. Biobehav. Rev., 21, 679-698.
18. WATERMAN, S.A. (2000). Voltage-gated calcium channels in autonomie neuroeffector transmission. Prog. Neurobiol., 60, 181-210.
19. WESSLER, I.K. & KIRKPATRICK, C.J. (2001). The non-neuronal cholinergic system: an emerging drug target in the airways. Pulmon. Pharmacol. Ther., 14, 423-434.